CORONA - COVMon - Monitoring concepts for SARS-CoV-2 - epidemiology and co-infections; subproject 3

  • Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Total publications:0 publications

Grant number: 03COV16C

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $637,851.73
  • Funder

    Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Principal Investigator

    Petra Gastmeier
  • Research Location

    Germany
  • Lead Research Institution

    Charité - Universitätsmedizin Berlin
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

COVID-19 Patients in intensive care units (ITS) often need mechanical ventilation or even receive extracorporeal membrane oxygenation (ECMO) or extracorporeal lung assist (ECLA) procedures. These applications, together with the other invasive device applications on ITS (urinary tract catheters, vascular catheters) could lead to a high risk for nosocomial infections, but also multidrug-resistant pathogens (MRE) during the stay on the ITS. Currently, however, there is no system to record such NI and MRE systematically and in a uniform structure on a larger number of ITS in COVID-19 patients. In COVMon-TV3, a surveillance system for NI/MRE in COVID-19 ITS patients will be developed and applied. The data obtained will be used to calculate epidemiological characteristics. These data will be made available to the participating ITS in a suitable form together with reference data (feedback) and can thus be used for internal quality management. In addition, an analysis of the NI and MRE data in comparison to other ITS patients is to be carried out in order to be able to describe and present the risk for NI and MRE of COVID-19 patients to non-COVID-19 patients on ITS.